ROCKAWAY, N.J., Jan. 12, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that its gammaCore™ nVNS device has received ...

FREMONT, Calif.--(BUSINESS WIRE)-- Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has ...

In 1997, the FDA approved implanted vagus nerve stimulation (VNS) devices as an adjunctive therapy for reducing the frequency and severity of epileptic seizures in pharmaco-resistant epilepsy patients ...

Pulsetto has announced pricing updates for its compact, non-invasive, vagus nerve stimulation device. Vilnius, Lithuania - August 12, 2024 — Pulsetto is offering a price cut for its wearable device as ...

Pulsetto - known for delivering non-invasive, cervical vagus nerve stimulation through a hands-free, app-enabled wearable that promotes stress relief, mental clarity, and sleep support. The links in ...

Stimulating the vagus nerve using a vibrotactile device applied to a specific region of the outer ear reduces inflammatory responses, according to a new series of pilot clinical studies. These ...

Chicago, IL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional ...

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced it has completed all study ...

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health ® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that the first study subject ...

“Already we have established that our non-invasive cervical vagus stimulation device has shown large, rapid effects in clinically important biological measures,” stated Tivic Health Chief Scientific ...